Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Brenner

Showing results (61-70 of 298) with videos related to

Pageof 30
Sort By:
Frontiers in Physiology|February 13, 2016
The Role of NADPH Oxidases (NOXs) in Liver Fibrosis and the Activation of MyofibroblastsShuang Liang, Tatiana Kisseleva, David A Brenner
Gastroenterology|June 19, 2012
A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approachesEkihiro Seki, David A Brenner, Michael Karin
Gastroenterology|July 13, 2006
NADPH oxidase in the liver: defensive, offensive, or fibrogenic?Samuele De Minicis, Ramón Bataller, David A Brenner
Gastroenterology|May 16, 2006
Toll-like receptor signaling in the liverRobert F Schwabe, Ekihiro Seki, David A Brenner
Current Opinion in Gastroenterology|April 9, 2015
Aging and liver diseaseIn Hee Kim, Tatiana Kisseleva, David A Brenner
Plos One|September 6, 2022
Multiplex short tandem repeat profiling of immortalized hepatic stellate cell line Col-GFP HSCSteffen K Meurer, David A Brenner, Ralf Weiskirchen
Frontiers in Bioscience : a Journal and Virtual Library|November 29, 2002
Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cellErwin Gäbele, David A Brenner, Richard A Rippe
Hepatology (Baltimore, Md.)|February 26, 2003
Genetic polymorphisms and the progression of liver fibrosis: a critical appraisalRamón Bataller, Kari E North, David A Brenner
Blood|August 1, 2002
An exon 10 deletion in the mouse ferrochelatase gene has a dominant-negative effect and causes mild protoporphyriaScott T Magness, Nobuyo Maeda, David A Brenner
Digestive Diseases (Basel, Switzerland)|March 2, 2006
Molecular mechanisms of alcohol-induced hepatic fibrosisSoren V Siegmund, Steven Dooley, David A Brenner
Pageof 30

Showing results (61-70 of 298) with videos related to

Sort By:
Pageof 30
Frontiers in Physiology|February 13, 2016
The Role of NADPH Oxidases (NOXs) in Liver Fibrosis and the Activation of MyofibroblastsShuang Liang, Tatiana Kisseleva, David A Brenner
Gastroenterology|June 19, 2012
A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approachesEkihiro Seki, David A Brenner, Michael Karin
Gastroenterology|July 13, 2006
NADPH oxidase in the liver: defensive, offensive, or fibrogenic?Samuele De Minicis, Ramón Bataller, David A Brenner
Gastroenterology|May 16, 2006
Toll-like receptor signaling in the liverRobert F Schwabe, Ekihiro Seki, David A Brenner
Current Opinion in Gastroenterology|April 9, 2015
Aging and liver diseaseIn Hee Kim, Tatiana Kisseleva, David A Brenner
Plos One|September 6, 2022
Multiplex short tandem repeat profiling of immortalized hepatic stellate cell line Col-GFP HSCSteffen K Meurer, David A Brenner, Ralf Weiskirchen
Frontiers in Bioscience : a Journal and Virtual Library|November 29, 2002
Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cellErwin Gäbele, David A Brenner, Richard A Rippe
Hepatology (Baltimore, Md.)|February 26, 2003
Genetic polymorphisms and the progression of liver fibrosis: a critical appraisalRamón Bataller, Kari E North, David A Brenner
Blood|August 1, 2002
An exon 10 deletion in the mouse ferrochelatase gene has a dominant-negative effect and causes mild protoporphyriaScott T Magness, Nobuyo Maeda, David A Brenner
Digestive Diseases (Basel, Switzerland)|March 2, 2006
Molecular mechanisms of alcohol-induced hepatic fibrosisSoren V Siegmund, Steven Dooley, David A Brenner
Pageof 30